President Donald Trump’s threat to impose 30% tariffs on the European Union starting Aug. 1 disrupted negotiations and risks ...

Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.

Healthcare chief financial officers are shifting their strategic focus toward managing external disruptions, according to ...

European shares were unchanged on Friday, as losses in heavyweight healthcare shares were countered by an advance in oil and ...

Some GOP lawmakers and pro-trade lobbyists are quietly seeking to rein in the most extreme elements of the Trump ...

The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...

Australia is evaluating the impact of potential US tariffs of 200% on pharmaceutical imports, Treasurer Jim Chalmers said, while reiterating that his nation’s subsidies for certain drugs are not up ...

Small and medium-sized firms like Mitsuwa Electric that form the backbone of Japan's economy have weathered many storms over ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

In April, Trump announced a 25% tariff on U.S. imports from South Korea as part of his broader “Liberation Day” trade package ...

Consumers picked up their spending in June showing resilience despite anxiety high over tariffs and the U.S. economy.

Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...